BIO SURVEY FINDS 36 OF 107 COMPANIES HAVE LESS THAN ONE YEAR OF CASH
BIO SURVEY FINDS 36 OF 107 COMPANIES HAVE LESS THAN ONE YEAR OF CASH on hand. The Biotechnology Industry Organization survey, conducted by Robert Goldberg, PhD, Brandeis University, found that 11 of 107 respondents had six months or less cash on hand, and 75% of the respondents had two years or less cash available. BIO announced the survey results at a March 8 press conference on Capitol Hill.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth